Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • Autologous Hematopoietic Stem CellsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Autologous Hematopoietic Stem CellsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(50%)
Terminated
1(50%)

Phase Distribution

Phase 1
1
50%
Phase 1/2
1
50%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 1/2Combined phases
1(50.0%)

Highest Phase Reached

Phase 1/2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Terminated(1)

Detailed Status

Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
0.0%
Most Advanced
Phase 1/2

Trials by Phase

Phase 11 (50.0%)
Phase 1/21 (50.0%)

Trials by Status

terminated150%
recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
recruitingphase_1

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

NCT04150042
terminatedphase_1_2

Stem Cell Transplantation for Stiff Person Syndrome (SPS)

NCT02282514

Clinical Trials (2)

Showing 2 of 2 trials
NCT04150042Phase 1

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Recruiting
NCT02282514Phase 1/2

Stem Cell Transplantation for Stiff Person Syndrome (SPS)

Terminated

All 2 trials loaded

Drug Details

Intervention Type
Varies by study
Total Trials
2